LENZ THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
LENZ THERAPEUTICS, INC. (LENZ) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 564.00 thousand shares as of 2023-01-01, per its 10-K filed 2024-02-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2024-02-27
- 2023-01-01: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 564.00K shares.
- 2022-01-01: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 564.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized |
|---|---|
| 2023-01-01 | 564.00K shares 10-K · filed 2024-02-27 |
| 2022-01-01 | 564.00K shares 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |